Next-generation sequencing (NGS) targeting 1,267 genes identified a rare novel rhabdomyosarcoma 2-associated transcript (RMST)-ALK translocation (R5′UTR: A20) and an ALK-intergenic (A19: intergenic) rearrangement (Figure 1A). Here, ALK is linked to rhabdomyosarcoma.